Community Engagement Alliance Against Disparities
Launched by JOHNS HOPKINS UNIVERSITY · Sep 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Community Engagement Alliance Against Disparities (CEAL DMV) is a research project aimed at improving health in Black and Latino communities in Washington, D.C., Maryland, and Virginia. This study focuses on conditions like diabetes, pre-diabetes, hypertension, and obesity. The goal is to build strong relationships between communities and universities to help reduce health disparities and create a supportive environment for better health.
To participate, you need to be at least 18 years old, identify as Black or Latino, and live in a specific area. You should also have one of the health conditions mentioned, such as diabetes or high blood pressure. Participants will engage with community partners and researchers to share experiences and help develop solutions together. If you’re interested, please know that they are currently looking for volunteers, and you will need access to a phone or internet to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identify as Black or Latino
- • Age 18 years or older
- • Reside in defined geographic area
- • Diagnosis of one or more target conditions: Prediabetes/Diabetes (HbA1c 5.7%), Hypertension (≥130/80 mm Hg), Overweight/obesity (BMI \>25 kg/m\^2)
- Exclusion Criteria:
- • Unable to provide informed consent
- • No access to phone/internet
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Cheryl Himmelfarb, PhD, MSN, BS
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported